Latest filing published 21 Aug 2007 for AURIGA LABORATORIES, INC., €648.
No signal scores available.
This profile gathers the share dealings of Andrew Shales in Auriga Laboratories, Inc. We count 134 filings; the first trade dates from 25 August 2006 and the latest from 17 August 2007.
Sales make up the whole of the open-market record (131 sales, €43k). Outside the open market, there are 3 share grants. Since January 2007: no purchases and 110 sales on the market.
On 21 August 2007 came the latest disclosure, an open-market sale for €1,390 in Auriga Laboratories, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 94 declarations